Breaking News Instant updates and real-time market news.

AET

Acquired by CVS

$205.78

1.635 (0.80%)

, CVS

CVS Health

$75.77

0.25 (0.33%)

12:02
11/21/18
11/21
12:02
11/21/18
12:02

NJ state clears CVS-Aetna merger

According to a filing, the State of New Jersey's Department of Banking and Insurance has approved the proposal of CVS Health (CVS) to acquire control of Aetna Health (AET), Aetna Better Health, and Aetna Dental Health, subject to CVS and Aetna complying with all applicable laws regarding the dissolution of Hudson Merger Sub Corp., an entity established for the purpose of merging with Aetna for the purposes of this acquisition. Reference Link

AET

Acquired by CVS

$205.78

1.635 (0.80%)

CVS

CVS Health

$75.77

0.25 (0.33%)

  • 27

    Nov

AET Acquired by CVS
$205.78

1.635 (0.80%)

11/08/18
LEER
11/08/18
NO CHANGE
Target $95
LEER
Outperform
CVS Health price target raised to $95 from $85 at Leerink
Leerink analyst David Larsen raised his price target for CVS Health (CVS) to $95 from $85 following quarterly results. The analyst is encouraged that the deal with Aetna (AET) appears to be ready to close in the near-term, which he believes will be a positive catalyst for the stock. Larsen also likes how the PBM selling season seems to be progressing well, better than he had expected, and also likes how CVS seems to be re-focusing on the Retail "Streamline" efforts, which will hopefully result in net savings in 2019. The analyst reiterates an Outperform rating on CVS shares.
11/13/18
ARGS
11/13/18
NO CHANGE
Target $100
ARGS
Buy
CVS Health price target raised to $100 from $88 at Argus
Argus analyst Chris Graja raised his price target on CVS Health (CVS) to $100 and kept his Buy rating after its Q3 earnings beat, saying he remains "bullish on the management's ability to find innovative and profitable ways to reduce healthcare costs and deliver better care". The analyst also notes that he sees "significant upside for the shares if the company can close acquisition of Aetna (AET) and deliver on its financial targets". To that end, Graja cites the management's confidence expressed on the earnings call that the transaction can be closed prior to Thanksgiving and yield more than the initially estimated $750M in 2-year synergy benefits.
11/21/18
JEFF
11/21/18
NO CHANGE
JEFF
Jefferies not sure how Humana would benefit from Walgreens stake
The stake talks between Walgreens Boots Alliance (WBA) and Humana (HUM), as reported last night by the Wall Street Journal, follows in the pattern of the Aetna (AET)/CVS Health (CVS) deal, but it is not fully clear how Humana would benefit from an investment in Walgreens, Jefferies analyst Brian Tanquilut tells investors in a research note. For Walgreens, a partnership approach matches the company's strategy and would help address questions about the long-term viability of the retail pharmacy model, adds the analyst. He believes partnering with Humana helps Walgreens drive market share. Further, a deal could also help strengthen Humana's brand and improve its ability to market directly to prospective insurance lives, especially as healthcare increasingly becomes consumer-focused, Tanquilut says.
11/21/18
LEER
11/21/18
NO CHANGE
LEER
Humana-Walgreens strategic deal makes sense, takeout less likely, says Leerink
Following a media report saying that Humana (HUM) and Walgreens Boots Alliance (WBA) are in talks to take stakes in each other and possibly expand their retail clinic partnership inked on June 19, Leerink analyst Ana Gupte says she believes it makes strategic sense, though she believes an outright takeout is less likely given the multiple differential. As MCOs backward integrate into care delivery, the analyst believes a closer strategic alignment between the two companies can help Humana better compete with the likes of CVS (CVS)-Aetna (AET) and Optum-UnitedHealth (UNH) in the Medicare Advantage market while allowing Walgreens to further stave off e-commerce threats such as Amazon (AMZN), though Humana maintains its strategic investment focus on the home healthcare setting for Seniors.
CVS CVS Health
$75.77

0.25 (0.33%)

11/19/18
JEFF
11/19/18
NO CHANGE
JEFF
Jefferies uncovers signs of Amazon expanding prescription drug presence
Jefferies analyst Brian Tanquilut says his proprietary checks of Amazon.com's (AMZN) moves in the pharmacy space indicate that the online retailer has finally made moves to expand PillPack. However, the initial expansion phase appears focused on offering pharmacy services to Amazon employees in Washington. In his most recent webscrape, Tanquilut came across a new prescription license in WA, two pending Rx licenses in New Mexico and Indiana, and pharmacy technician and packaging/shipping job postings all linked to PillPack's Phoenix facility. These new developments signal the beginning of Amazon's prescription expansion via PillPack, Tanquilut tells investors in a research note. If Amazon were to rollout a more extensive PillPack offering to its own employee base, Rite Aid (RAD) could be most exposed to potential script transfers with Walgreens Boots Alliance (WBA) the least exposed among the public drugstores, says the analyst. He still believes that the impact of Amazon's pharmacy entry will take a while to materialize for drug stores CVS Health (CVS) and Walgreens.

TODAY'S FREE FLY STORIES

LYFT

Lyft

$0.00

(0.00%)

18:41
03/19/19
03/19
18:41
03/19/19
18:41
Periodicals
Lyft IPO oversubscribed so far, Reuters reports »

Lyft's IPO is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 21

    Mar

  • 21

    Mar

  • 22

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

NSTG

NanoString

$24.27

-3.03 (-11.10%)

18:37
03/19/19
03/19
18:37
03/19/19
18:37
Syndicate
NanoString 4.5M share Secondary priced at $23.00 »

JPMorgan, UBS and Cowen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

GLD

SPDR Gold Shares

$123.39

0.35 (0.28%)

18:37
03/19/19
03/19
18:37
03/19/19
18:37
Hot Stocks
Breaking Hot Stocks news story on SPDR Gold Shares »

SPDR Gold Shares holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCLH

Norwegian Cruise Line

$56.11

-0.03 (-0.05%)

18:33
03/19/19
03/19
18:33
03/19/19
18:33
Hot Stocks
Norwegian Cruise Line CEO: There is no recession »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

NTNX

Nutanix

$38.78

0.425 (1.11%)

18:23
03/19/19
03/19
18:23
03/19/19
18:23
Hot Stocks
Nutanix CEO: Our churn is really small »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

  • 04

    Apr

  • 09

    Jul

FDX

FedEx

$181.50

-0.92 (-0.50%)

18:20
03/19/19
03/19
18:20
03/19/19
18:20
Earnings
FedEx says started FY19 expecting revenue to rise $6B, but will see $4.5B »

This implies FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

SAGE

Sage Therapeutics

$156.08

-0.89 (-0.57%)

18:04
03/19/19
03/19
18:04
03/19/19
18:04
Hot Stocks
FDA approves Sage Therapeutics' Zulresso in PPD treatment »

The FDA approved Zulresso…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

FDX

FedEx

$181.50

-0.92 (-0.50%)

18:02
03/19/19
03/19
18:02
03/19/19
18:02
Hot Stocks
FedEx says reviewing capital expense plan for FY20 »

Sees FY19 effective tax…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

BAYRY

Bayer

$0.00

(0.00%)

17:58
03/19/19
03/19
17:58
03/19/19
17:58
Periodicals
Bayer to face liability in second phase of Roundup trial, Bloomberg says »

Bayer has lost the first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

FDX

FedEx

$181.50

-0.92 (-0.50%)

17:57
03/19/19
03/19
17:57
03/19/19
17:57
Hot Stocks
FedEx says higher operating costs likely to continue to impact results »

Says will know about…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

GPRO

GoPro

$6.26

0.005 (0.08%)

17:51
03/19/19
03/19
17:51
03/19/19
17:51
Periodicals
GoPro rival China's Insta360 plans 2020 IPO, CNBC says »

GoPro rival Insta360,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$181.50

-0.92 (-0.50%)

, AMZN

Amazon.com

$1,762.45

20.45 (1.17%)

17:47
03/19/19
03/19
17:47
03/19/19
17:47
Hot Stocks
FedEx Co-CEO Carter says Amazon not a threat to future growth »

Says well placed to take…

FDX

FedEx

$181.50

-0.92 (-0.50%)

AMZN

Amazon.com

$1,762.45

20.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 26

    Mar

  • 01

    Apr

  • 02

    Apr

  • 04

    Apr

FRBA

First Bank

$11.41

-0.14 (-1.21%)

17:46
03/19/19
03/19
17:46
03/19/19
17:46
Hot Stocks
First Bank to acquire Grand Bank for $19.4M »

First Bank and Grand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTSH

Cognizant

$72.00

0.13 (0.18%)

17:42
03/19/19
03/19
17:42
03/19/19
17:42
Hot Stocks
Cognizant President Rajeev Mehta sells over $1.4M in company shares »

Cognizant President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

ENT

Global Eagle

$1.16

-0.14 (-10.77%)

17:42
03/19/19
03/19
17:42
03/19/19
17:42
Downgrade
Global Eagle rating change  »

Global Eagle downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$181.50

-0.92 (-0.50%)

17:40
03/19/19
03/19
17:40
03/19/19
17:40
Hot Stocks
FedEx CEO Fred Smith says Q3 was a 'challenging quarter' »

Says "we're…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

AMRS

Amyris

$3.88

0.05 (1.31%)

17:31
03/19/19
03/19
17:31
03/19/19
17:31
Hot Stocks
Amyris to delay filing 10-K, may have further financial reporting deficiences »

Amyris was unable to file…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$296.55

-1.105 (-0.37%)

17:22
03/19/19
03/19
17:22
03/19/19
17:22
Hot Stocks
Lockheed Martin awarded $264.66M contract modification for Korea F-35 program »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

QHC

Quorum Health

$1.89

-0.02 (-1.05%)

17:20
03/19/19
03/19
17:20
03/19/19
17:20
Hot Stocks
York Capital reports 8.18% passive stake in Quorum Health »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

UPS

UPS

$110.37

-0.31 (-0.28%)

, FDX

FedEx

$181.50

-0.92 (-0.50%)

17:19
03/19/19
03/19
17:19
03/19/19
17:19
Hot Stocks
UPS falls after peer FedEx reports downbeat Q3 results, cuts FY19 EPS view »

UPS (UPS) is dropping in…

UPS

UPS

$110.37

-0.31 (-0.28%)

FDX

FedEx

$181.50

-0.92 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

  • 25

    Apr

BA

Boeing

$373.87

1.77 (0.48%)

17:19
03/19/19
03/19
17:19
03/19/19
17:19
Hot Stocks
Boeing awarded $326.3M Navy delivery order »

Boeing has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

BAYRY

Bayer

$0.00

(0.00%)

17:17
03/19/19
03/19
17:17
03/19/19
17:17
Periodicals
Bayer to face liability in second phase of Roundup trial, Bloomberg says »

Bayer has lost the first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

GD

General Dynamics

$170.72

-1.01 (-0.59%)

17:17
03/19/19
03/19
17:17
03/19/19
17:17
Hot Stocks
General Dynamics' Electric Boat awarded $2B contract modification »

The U.S. Navy has awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

DIS

Disney

$109.97

-3.1 (-2.74%)

, TFCFA

21st Century Fox

$49.62

(0.00%)

17:14
03/19/19
03/19
17:14
03/19/19
17:14
Hot Stocks
Disney, 21st Century Fox say per share value of merger $51.572626 »

The Walt Disney Company…

DIS

Disney

$109.97

-3.1 (-2.74%)

TFCFA

21st Century Fox

$49.62

(0.00%)

TFCF

21st Century Fox

$49.61

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

MOR

MorphoSys

$23.55

-0.165 (-0.70%)

17:13
03/19/19
03/19
17:13
03/19/19
17:13
Hot Stocks
MorphoSys, I-Mab Biopharma initiate phase 2 study of TJ202 for multiple myeloma »

China-based I-Mab…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 08

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.